TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest update is out from Integral Diagnostics Ltd. ( (AU:IDX) ).
Integral Diagnostics Ltd. announced the issuance of 214,921 performance rights under an employee incentive scheme. These unquoted securities are subject to transfer restrictions and are not listed on the ASX until these restrictions are lifted, potentially impacting employee retention and motivation.
The most recent analyst rating on (AU:IDX) stock is a Buy with a A$4.00 price target. To see the full list of analyst forecasts on Integral Diagnostics Ltd. stock, see the AU:IDX Stock Forecast page.
More about Integral Diagnostics Ltd.
Integral Diagnostics Ltd. operates in the healthcare industry, providing diagnostic imaging services. The company focuses on delivering high-quality radiology services across various regions, utilizing advanced technology and a skilled workforce to meet the needs of patients and healthcare providers.
Average Trading Volume: 1,063,185
Technical Sentiment Signal: Buy
Current Market Cap: A$1.01B
Find detailed analytics on IDX stock on TipRanks’ Stock Analysis page.